In vitro synergy testing of levofloxacin, ofloxacin, and ciprofloxacin in combination with aztreonam, ceftazidime, or piperacillin against Pseudomonas aeruginosa
- PMID: 11821176
- DOI: 10.1016/s0732-8893(01)00312-1
In vitro synergy testing of levofloxacin, ofloxacin, and ciprofloxacin in combination with aztreonam, ceftazidime, or piperacillin against Pseudomonas aeruginosa
Abstract
The synergistic potential of levofloxacin, ofloxacin and ciprofloxacin combined with aztreonam, ceftazidime, or piperacillin was compared using 24 strains of Pseudomonas aeruginosa with varying susceptibility profiles. Levofloxacin and ciprofloxacin demonstrated similar in vitro activity, with ofloxacin demonstrating less activity compared to the other agents. Predominantly additive effects were seen with all combinations, with no significant differences detected between the fluoroquinolone agents.
Similar articles
-
In vitro efficacy of levofloxacin alone or in combination tested against multi-resistant Pseudomonas aeruginosa strains.J Chemother. 1996 Dec;8(6):411-5. doi: 10.1179/joc.1996.8.6.411. J Chemother. 1996. PMID: 8981179
-
Comparison of the bactericidal activities of ofloxacin and ciprofloxacin alone and in combination with ceftazidime and piperacillin against clinical strains of Pseudomonas aeruginosa.Antimicrob Agents Chemother. 1995 Nov;39(11):2503-10. doi: 10.1128/AAC.39.11.2503. Antimicrob Agents Chemother. 1995. PMID: 8585734 Free PMC article. Clinical Trial.
-
Cefepime, piperacillin/tazobactam, gentamicin, ciprofloxacin, and levofloxacin alone and in combination against Pseudomonas aeruginosa.Diagn Microbiol Infect Dis. 2002 Sep;44(1):35-41. doi: 10.1016/s0732-8893(02)00420-0. Diagn Microbiol Infect Dis. 2002. PMID: 12376029
-
Levofloxacin, a broad spectrum anti-infective: from Streptococcus pneumoniae to Pseudomonas aeruginosa.J Chemother. 2004 Apr;16 Suppl 2:3-7. doi: 10.1080/1120009x.2004.11782365. J Chemother. 2004. PMID: 15255554 Review. No abstract available.
-
Naturally occurring monobactams.Adv Appl Microbiol. 1986;31:181-205. doi: 10.1016/s0065-2164(08)70442-8. Adv Appl Microbiol. 1986. PMID: 3521210 Review. No abstract available.
Cited by
-
Microparticles for inhalational delivery of antipseudomonal antibiotics.AAPS J. 2008 Jun;10(2):254-60. doi: 10.1208/s12248-008-9033-8. Epub 2008 May 3. AAPS J. 2008. PMID: 18454321 Free PMC article.
-
In Vitro Synergy of Levofloxacin Plus Piperacillin/Tazobactam against Pseudomonas aeruginosa.Interdiscip Perspect Infect Dis. 2009;2009:984934. doi: 10.1155/2009/984934. Epub 2009 Nov 8. Interdiscip Perspect Infect Dis. 2009. PMID: 19911066 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources